The invention relates to a
precipitation strengthening type biomedical
magnesium alloy capable of being degraded
in vivo and a preparation process of the
precipitation strengthening type biomedical
magnesium alloy. The
magnesium alloy comprises the following components in percentage by
mass: 5.0-6.0% of Zn, 1.0-2.0% of Yb, 0.3-0.5% of Zr and the balance Mg. A submicron second phase is dispersed and distributed in a magnesium matrix. The process comprises the following steps:
smelting an alloy
ingot according to design components to ensure that initial grains are equiaxed, uniform and fine, carrying out
solution treatment to ensure that the second phase is fully dissolved into the matrix, and carrying out aging treatment to fully disperse and separate out the submicron second phase. The
magnesium alloy prepared by the process has the advantages of
corrosion resistance, high strength, good
biocompatibility and complete degradation
in vivo, and is suitable for biological implants such as intravascular stents, bone nails, bone lamellas and the like which simultaneously require certain strength and
corrosion service cycle. According to the
precipitation strengthening type biomedical
magnesium alloy and the preparation process, the heavy
rare earth element
ytterbium (Yb) is introduced into an alloy
system so as to regulate and control the morphology and distribution of a precipitated phase, the
corrosion resistance of a matrix alloy is effectively improved while the matrix is strengthened by means of dispersed precipitation of the fine second phase, and the problem of too fast corrosion in
biomedicine is solved. The preparation process is universal and efficient, and has a good popularization prospect.